BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34113210)

  • 1. Breast Cancer Screening Program in Lithuania: Trends in Breast Cancer Mortality Before and During the Introduction of the Mammography Screening Program.
    Steponavičienė L; Briedienė R; Vansevičiūtė-Petkevičienė R; Gudavičienė-Petkevičienė D; Vincerževskienė I
    Acta Med Litu; 2020; 27(2):61-69. PubMed ID: 34113210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania.
    Steponaviciene L; Briediene R; Vanseviciute R; Smailyte G
    Cancer Control; 2019; 26(1):1073274818821096. PubMed ID: 30808202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of breast cancer mortality considering the implementation of mammography screening programs - a comparison of western European countries.
    Iwamoto Y; Kaucher S; Lorenz E; Bärnighausen T; Winkler V
    BMC Public Health; 2019 Jun; 19(1):823. PubMed ID: 31242882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population.
    Simbrich A; Wellmann I; Heidrich J; Heidinger O; Hense HW
    Cancer Epidemiol; 2016 Oct; 44():44-51. PubMed ID: 27470937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of time trends in breast and prostate cancer mortality rates in Lithuania, 1986-2020.
    Everatt R; Gudavičienė D
    BMC Public Health; 2022 Sep; 22(1):1812. PubMed ID: 36151551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of advanced-stage breast cancer in regular participants of a mammography screening program: a prospective register-based study.
    Khil L; Heidrich J; Wellmann I; Kääb-Sanyal V; Weigel S; Heindel W; Hense HW; Heidinger O
    BMC Cancer; 2020 Mar; 20(1):174. PubMed ID: 32131766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structured screening for sporadic breast cancer].
    Weigel S; Katalinic A
    Radiologie (Heidelb); 2024 Jun; 64(6):463-470. PubMed ID: 38499691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mammography screening on surgical treatment for breast cancer: a nationwide analysis of hospitalization rates in Germany 2005-2009.
    Stang A; Kääb-Sanyal V; Hense HW; Becker N; Kuss O
    Eur J Epidemiol; 2013 Aug; 28(8):689-96. PubMed ID: 23775424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in surgical treatment for breast cancer in Germany after the implementation of the mammography screening program.
    Trocchi P; Kuss O; Kääb-Sanyal V; Heidinger O; Stang A
    Eur J Epidemiol; 2019 Dec; 34(12):1143-1150. PubMed ID: 31650416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the impact of the mammography screening program on breast cancer mortality: feasibility study on linking several data sources in North Rhine-Westphalia].
    Fuhs A; Bartholomäus S; Heidinger O; Hense HW
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):60-7. PubMed ID: 24357174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study.
    Mukhtar TK; Yeates DR; Goldacre MJ
    J R Soc Med; 2013 Jun; 106(6):234-42. PubMed ID: 23761583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
    Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
    Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies.
    Herrmann C; Vounatsou P; Thürlimann B; Probst-Hensch N; Rothermundt C; Ess S
    BMJ Open; 2018 Mar; 8(3):e017806. PubMed ID: 29540406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the incidence and mortality of kidney cancer in Lithuania from 1993 to 2012.
    Patašius A; Ulytė A; Ulys A; Smailytė G
    Acta Med Litu; 2018; 25(3):151-160. PubMed ID: 30842704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Motivation to participate in mammography screening program for breast cancer].
    Boguseviciūte A; Dirzyte A; Bogusevicius A
    Medicina (Kaunas); 2003; 39(10):1007-15. PubMed ID: 14578646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and validity of the Champion's Health Belief Model Scale among Lithuanian women.
    Zelviene A; Bogusevicius A
    Cancer Nurs; 2007; 30(3):E20-8. PubMed ID: 17510578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography screening and breast cancer mortality in Sweden.
    Autier P; Koechlin A; Smans M; Vatten L; Boniol M
    J Natl Cancer Inst; 2012 Jul; 104(14):1080-93. PubMed ID: 22811439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer incidence and mortality before and after implementation of the German mammography screening program.
    Katalinic A; Eisemann N; Kraywinkel K; Noftz MR; Hübner J
    Int J Cancer; 2020 Aug; 147(3):709-718. PubMed ID: 31675126
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.